These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17461712)

  • 21. Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3.
    Lubenow N; Eichler P; Lietz T; Greinacher A;
    J Thromb Haemost; 2005 Nov; 3(11):2428-36. PubMed ID: 16241940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.
    Oh JJ; Akers WS; Lewis D; Ramaiah C; Flynn JD
    Pharmacotherapy; 2006 Apr; 26(4):569-577. PubMed ID: 16553518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lepirudin for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 1998 Sep; 40(1036):94-5. PubMed ID: 9774965
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute urticaria caused by subcutaneous recombinant hirudin: evidence for an IgG-mediated hypersensitivity reaction.
    Bircher AJ; Czendlik CH; Messmer SL; Müller P; Howald H
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):994-6. PubMed ID: 8939165
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biventricular thrombus resolution and antibody formation during lepirudin therapy. Comment on the article from DMW 28-29/2003].
    Nowak G
    Dtsch Med Wochenschr; 2003 Nov; 128(45):2389-90; author reply 2390. PubMed ID: 14606040
    [No Abstract]   [Full Text] [Related]  

  • 26. [A case of heparin induced thrombocytopenia treated with lepirudin infusion: case report].
    Sünmez S; Okumuş G; Kiyan E; Ece T; Arseven O
    Tuberk Toraks; 2006; 54(2):185-8. PubMed ID: 16924578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lepirudin anticoagulation for heparin-induced thrombocytopenia.
    Deitcher SR; Topoulos AP; Bartholomew JR; Kichuk-Chrisant MR
    J Pediatr; 2002 Feb; 140(2):264-6. PubMed ID: 11865285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lepirudin dosing in dialysis-dependent renal failure.
    Wittkowsky AK; Kondo LM
    Pharmacotherapy; 2000 Sep; 20(9):1123-8. PubMed ID: 10999507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudin.
    Eichler P; Lubenow N; Strobel U; Greinacher A
    Blood; 2004 Jan; 103(2):613-6. PubMed ID: 14512301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
    Fabrizio MC
    J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trousseau's syndrome treated with long-term subcutaneous lepirudin (case report and review of the literature).
    Andreescu AC; Cushman M; Hammond JM; Wood ME
    J Thromb Thrombolysis; 2001 Feb; 11(1):33-7. PubMed ID: 11248788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interference of thrombin in immunological assays for hirudin specific antibodies.
    Hamilton RG; Levy JH; Marder VJ; Sane DC
    J Immunol Methods; 2012 Jul; 381(1-2):50-8. PubMed ID: 22542931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Removal of lepirudin used as an anticoagulant in mechanical autotransfusion with Cell-Saver 5].
    Marx A; von Lüpke U; Tessmann R; Lindhoff-Last E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Mar; 36(3):162-6. PubMed ID: 11324348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of heparin versus lepirudin flushes to prevent withdrawal occlusion of central venous access devices.
    Horne MK; McCloskey DJ; Calis K; Wesley R; Childs R; Kasten-Sportes C
    Pharmacotherapy; 2006 Sep; 26(9):1262-7. PubMed ID: 16945048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot study.
    Riess FC; Poetzsch B; Madlener K; Cramer E; Doll KN; Doll S; Lorke DE; Kormann J; Mueller-Berghaus G
    Thorac Cardiovasc Surg; 2007 Jun; 55(4):233-8. PubMed ID: 17546553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of continuous venovenous hemofiltration for reversal of anticoagulation with lepirudin post-cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia after heart transplantation.
    Saravanan P; Rege K; Falter F
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):269-72. PubMed ID: 17418747
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy.
    Greinacher A
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):339-57. PubMed ID: 15151481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation.
    Dager WE; Gosselin RC; Yoshikawa R; Owings JT
    Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis.
    Pöschel KA; Bucha E; Esslinger HU; Ulbricht K; Nörtersheuser P; Stein G; Nowak G
    Kidney Int; 2004 Feb; 65(2):666-74. PubMed ID: 14717940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.